trending Market Intelligence /marketintelligence/en/news-insights/trending/WtVMEwrcvwwPaQxunpTZDA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Report: DuPont de Nemours reviewing options for nutrition, biosciences unit

Assessing The Impact Of COVID-19 On Businesses: Changes Happening With More On The Way

Small Scale Solar Projects by the Numbers

Infographic: Solar Power by the Numbers - The U.S., Canada and Mexico

Industries Most and Least Impacted by COVID 19 from a Probability of Default Perspective March 2020 Update

Report: DuPont de Nemours reviewing options for nutrition, biosciences unit

Specialty chemicals company DuPont de Nemours Inc. is evaluating options for its nutrition and biosciences segment, including a sale, spinoff or tax-free merger, Bloomberg News reported, citing people familiar with the matter.

DowDuPont Inc. changed its name to DuPont de Nemours Inc. following its break-up.

The nutrition and biosciences segment could reportedly be valued at a minimum of $20 billion. Givaudan SA, Koninklijke DSM NV, Kerry Group PLC and International Flavors & Fragrances Inc. could be potential candidates for a tax-free merger, according to the report.

However, the review is in the early stages, and the company may opt not to pursue a potential sale, the people told Bloomberg News.

DuPont de Nemours booked a net loss attributable to DuPont common stockholders of $571 million in the second quarter ended June 30, with net sales falling 7% on a yearly basis.